Home › Crohn's Disease › NCT04617184
Registry and Biorepository for IBD in Central Texas
Registry and Biorepository for the Study of Inflammatory Bowel Diseases in Central Texas
Who can join
Ages 18 to 100 · All sexes
Full eligibility criteria
Inclusion Criteria: * Male or female, age 18 years or older * Willing and able to provide written consent for participation in the registry and biorepository * Patients with known or suspected inflammatory bowel disease Exclusion Criteria: * Patient is unable to comprehend and/or cooperate with study activities * Patient is too ill to provide consent * Coagulopathy that precludes safe biopsy of the bowel * Comorbidity that precludes safe participation in endoscopic procedures
About the study
This is a prospective, non-interventional registry and biorepository for patients with IBD. Longitudinal follow-up data is collected from both patients and their treating gastroenterologist during routine clinical encounters. The biorepository will consist of prospective collection of blood samples, tissue samples, and fecal samples for research purposes, while the participants are undergoing a clinically-indicated procedure (i.e. venipuncture for routine tests, IV catheter placement, and/or endoscopy). Participants may choose to provide any or all of the aforementioned information and/or samples.
What is being tested
- NO INTERVENTION (other)
Sponsor: University of Texas at Austin · Participants: 1,000 · Started: Jun 1, 2021
Contact the study team
- Benjamin Chebaa, BA · Phone: 5124955641
Official record on ClinicalTrials.gov — NCT04617184
Locations in the U.S.
| Texas | Dell Medical School, UT Austin, Austin |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.